- Investigator
- Dominick J Angiolillo
- Status
- Accepting Candidates
- Ages
- 45 Years - 99 Years
- Sexes
- All
Treats Adults
Dominick J Angiolillo, MD, PhD
Cardiologist, Interventional Cardiologist
Dominick J Angiolillo, MD, PhD
- Additional languages:
- Italian,
- Spanish
(904) 383-1011
Request appointment online
Research at a glance
Top areas of exploration
- Platelet Aggregation Inhibitors , 416 publications
- Percutaneous Coronary Intervention , 211 publications
- Clopidogrel , 189 publications
- Ticlopidine , 158 publications
Research activity
Active clinical trials
- Investigator
- Dominick J Angiolillo
- Status
- Accepting Candidates
- Ages
- 18 Years - 99 Years
- Sexes
- All
- Investigator
- Dominick J Angiolillo
- Status
- Accepting Candidates
- Ages
- 18 Years - 65 Years
- Sexes
- All
My publications
Filter publications
844 publications
2026
Residual cardiovascular risk in coronary artery disease: from pathophysiology to established and novel therapies
Nature Reviews Cardiology
2025
The role of oxidized phospholipids on thrombotic risk
Journal of Thrombosis and Thrombolysis
2025
Aspirin or P2Y12 inhibitor monotherapy in atherosclerotic cardiovascular disease?
European Heart Journal
2025
Cardiovascular Effects and Tolerability of GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis of 99,599 Patients.
Journal of the American College of Cardiology
鈥�2025
Early Withdrawal of Aspirin after PCI in Acute Coronary Syndromes.
The New England journal of medicine
鈥�